Clinical Trial Update: Virtue® SAB in the Treatment of Coronary ISR Trial [NA]

View source ↗

Summary

This entry reports that the Virtue SAB trial from Orchestra BioMed is currently recruiting to evaluate treatment of in-stent restenosis in patients with coronar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Virtue SAB

Snippet

Sponsor: Orchestra BioMed, Inc | Conditions: Coronary Artery Disease | NA | Status: RECRUITING